About Stacey Pugh
Stacey Pugh is Endogenex's chief executive officer. She is also a director. Endogenex develops an outpatient endoscopic procedure using non-thermal pulsed electric fields. The investigational system is being studied in people with type 2 diabetes.
Her 20 years in medical technology span research, product development and device commercialization. She became Butterfly Network's chief commercial officer in March 2021. Before that, she led Medtronic's Neurovascular business as senior vice president and president from October 2020 to March 2021. She earlier served as vice president and general manager for that business. At Covidien, she was vice president of global medical affairs and clinical affairs for the Neurovascular Division. Kinetic Concepts employed her in several clinical development roles for almost eight years. She began in critical care, trauma nursing and nursing education, and directed human-subject research at Texas Tech University Health Sciences Centers.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Stacey Pugh in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stacey Pugh works with at each company, as listed on that company's latest Form D.
